Go to top of page

 Consolidated Cash Flow Statement

for the year ended 30 June 2019

Notes

2019 1

$’000

2018

$’000

OPERATING ACTIVITIES

Cash received

Interest and fees

147,288

113,691

Income distributions from trusts and equity investments

14,748

10,144

Total cash received

162,036

123,835

Cash used

Employees

25,834

22,896

Suppliers

9,806

7,102

Total cash used

35,640

29,998

Net cash from operating activities

126,396

93,837

INVESTING ACTIVITIES

Cash received

Principal loan repayments received

196,818

184,084

Sale of other debt securities

83,711

20,177

Sale of equities and units in trusts

24,213

70

Sale of investment in associate

40,667

Redemption of other financial assets

266,308

Distributions from associates and joint ventures

4,199

506

Total cash received

349,608

471,145

Cash used

Loans made to other parties

682,591

1,340,992

Purchase of other debt securities

278,937

504,331

Purchase of equities and units in trusts

79,751

96,207

Acquisition of other financial assets

154,550

Investment in associates and joint ventures

171,007

81,835

Purchase of property, plant and equipment

193

959

Purchase of computer software

518

328

Total cash used

1,212,997

2,179,202

Net cash used by investing activities

(863,389)

(1,708,057)

FINANCING ACTIVITIES

Cash received

Contributed equity

600,000

1,700,000

Total cash received

600,000

1,700,000

Net cash from financing activities

600,000

1,700,000

Net (decrease)/increase in cash held

(136,993)

85,780

Cash and cash equivalents at the beginning of the reporting period

487,754

401,974

Cash and cash equivalents at the end of the reporting period

3.1A

350,761

487,754

  1. The 2019 financial results reflect the adoption of AASB 9 – Financial Instruments on 1 July 2018. As permitted by AASB 9, the Group has not restated previously reported financial periods. Refer to Note 1 for the impact, on the Group’s results, of the adoption of AASB 9.

The above statement should be read in conjunction with the accompanying notes.